IceCure Medical (ICCM) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ICCM filings

Are insiders buying or selling Icecure Medical (ICCM) stock?

Neither. Icecure Medical (ICCM) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ICCM recently?

None. No member of Congress disclosed a ICCM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ICCM smart-money data?

This summary uses filings available on Oct 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on ICCM

Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
Lean short1 buy · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ICCM filings

Are insiders buying or selling Icecure Medical (ICCM) stock?

Neither. Icecure Medical (ICCM) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ICCM recently?

None. No member of Congress disclosed a ICCM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ICCM smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 12, 2026

Earnings came in 127.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 12, 2026

Period ending

Jun 30, 2026

Earnings per share

-$3.11-127.01% miss

-$1.37 expected

Revenue (FY)

$3.4M

Year ended Dec 31, 2025 · SEC filing

Next report

Estimated report: Nov 18, 2026, in 19 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 12, 2026	-$3.11est. -$1.37	-127.01%miss	Not on file	Not on file
Mar 31, 2026Reported May 12, 2026	-$0.06est. -$0.05	-$0.01miss	Not on file	Not on file
Dec 31, 2025Reported Mar 17, 2026	-$1.80est. -$1.20	-50.00%miss	$3.4M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 19, 2025	-$1.80est. -$1.65	-9.09%miss	Not on file	Not on file
Jun 30, 2025Reported Aug 13, 2025	-$1.80est. -$1.95	+7.69%beat	$1.3M · 6MSEC filing	No year-ago quarter
Mar 31, 2025Reported May 28, 2025	-$1.80est. -$2.40	+25.00%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 27, 2025	-$0.08est. -$0.08	+$0.00in line	$3.3M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 26, 2024	-$2.40est. -$2.25	-6.67%miss	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $1.02
52-wk high: $23.50
High: $1.07
52-wk low: $0.85
Low: $1.01
Prev close: $1.00
Mkt cap: $4.5M
ROE: -228.3%
Beta: 0.43
P/S: 1.1x
P/B: 0.4x
Profit margin: +0.0%
Op margin: -487.8%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $5M

Valuation

P/S1.15
P/B0.39

Quality

Operating margin-487.8%
ROE-228.3%
ROA-73.9%

Growth

Beta0.43

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

14oversold

20D volatility

88%annualized

52-week range

$1.01

$0.84$23.50

20D support

$0.96recent floor

20D resistance

$1.82recent ceiling

Returns

5D -4.7%20D -41.6%60D -65.1%

Price vs moving averages

SMA20 -18.6%SMA50 -44.7%SMA200 -88.0%

Volume pace

1.97xvs prior 20D

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ICCM filings

Are insiders buying or selling Icecure Medical (ICCM) stock?

Neither. Icecure Medical (ICCM) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ICCM recently?

None. No member of Congress disclosed a ICCM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ICCM smart-money data?

Smart money on ICCM

Lean short1 source:
- Politicians

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
Lean short1 buy · 2 salesExecutive
Executive branch filings. Amounts are filing ranges, not prices, and filings can lag the trade.
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about ICCM filings

Are insiders buying or selling Icecure Medical (ICCM) stock?

Neither. Icecure Medical (ICCM) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ICCM recently?

None. No member of Congress disclosed a ICCM trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ICCM smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 12, 2026

Earnings came in 127.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 12, 2026

Period ending

Jun 30, 2026

Earnings per share

-$3.11-127.01% miss

-$1.37 expected

Revenue (FY)

$3.4M

Year ended Dec 31, 2025 · SEC filing

Next report

Estimated report: Nov 18, 2026, in 19 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 12, 2026	-$3.11est. -$1.37	-127.01%miss	Not on file	Not on file
Mar 31, 2026Reported May 12, 2026	-$0.06est. -$0.05	-$0.01miss	Not on file	Not on file
Dec 31, 2025Reported Mar 17, 2026	-$1.80est. -$1.20	-50.00%miss	$3.4M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 19, 2025	-$1.80est. -$1.65	-9.09%miss	Not on file	Not on file
Jun 30, 2025Reported Aug 13, 2025	-$1.80est. -$1.95	+7.69%beat	$1.3M · 6MSEC filing	No year-ago quarter
Mar 31, 2025Reported May 28, 2025	-$1.80est. -$2.40	+25.00%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 27, 2025	-$0.08est. -$0.08	+$0.00in line	$3.3M · FYSEC filing	No year-ago quarter
Sep 30, 2024Reported Nov 26, 2024	-$2.40est. -$2.25	-6.67%miss	Not on file	Not on file

Open: $1.02
52-wk high: $23.50
High: $1.07
52-wk low: $0.85
Low: $1.01
Prev close: $1.00
Mkt cap: $4.5M
ROE: -228.3%
Beta: 0.43
P/S: 1.1x
P/B: 0.4x
Profit margin: +0.0%
Op margin: -487.8%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $5M

Valuation

P/S1.15
P/B0.39

Quality

Operating margin-487.8%
ROE-228.3%
ROA-73.9%

Growth

Beta0.43

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

14oversold

20D volatility

88%annualized

52-week range

$1.01

$0.84$23.50

20D support

$0.96recent floor

20D resistance

$1.82recent ceiling

Returns

5D -4.7%20D -41.6%60D -65.1%

Price vs moving averages

SMA20 -18.6%SMA50 -44.7%SMA200 -88.0%

Volume pace

1.97xvs prior 20D

Icecure Medical

Smart money at a glance

What do analysts expect?

Questions about ICCM filings

Smart money on ICCM

Questions about ICCM filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 127.0% below what analysts expected.

Estimated report: Nov 18, 2026, in 19 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Icecure Medical

Smart money at a glance

What do analysts expect?

Questions about ICCM filings

Smart money on ICCM

Questions about ICCM filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 127.0% below what analysts expected.

Estimated report: Nov 18, 2026, in 19 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Icecure Medical

Overview

Questions about ICCM filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Icecure Medical

Overview

Questions about ICCM filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.